![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_123,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SonomaEye-full-color-vector%5B2%5D.png)
Orbits/Oculoplastic
Saturday, 3/21/2026
8:00 am – 9:30 am
Moderators: Reza Vagefi, MD and Bryan Winn, MD
8:05 am – 8:15 am: Role of Immunotherapy in Periocular Squamous Cell Carcinoma. Christopher Dermarkarian, MD
8:15 am – 8:25 am: Emerging Therapies for TED. Fatemeh Rajaii, MD, PhD
8:25 am – 8:35 am: Surgical Management of TED Following Teprotumumab Treatment. Louise Mawn, MD
8:35 am – 8:45 am: Thyroid Eye Disease: Considerations in the Medical Treatment and Demystifying Surgical Orbit Decompression. Jeremiah P. Tao, MD
8:45 am – 8:55 am: Combination Intervention in the Management of Orbital and Periorbital Vascular Anomalies. Joyce Teng, MD, PhD
8:55 am – 9:05 am: Orbital and Adnexal Necrotizing Fasciitis. Bryan Winn, MD
9:05 am – 9:15 am: Acute Invasive Fungal Rhino-Orbital Disease: Lessons Learned and the Path Forward. Reza Vagefi, MD
9:15 am – 9:30 am: All Speaker Discussion